(Q80792631)

English

Impact of previous bacille Calmette-Guérin failure pattern on subsequent response to bacille Calmette-Guérin plus interferon intravesical therapy

scientific article published on 01 February 2008

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18308107%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Impact of previous bacille Calmette-Guérin failure pattern on subsequent response to bacille Calmette-Guérin plus interferon intravesical therapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18308107%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18308107%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

author name string

Brian L Gallagher

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18308107%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Fadi N Joudi

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18308107%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

José L Maymí

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18308107%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

language of work or name

0 references

publication date

1 February 2008

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18308107%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18308107%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

71

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18308107%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18308107%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

297-301

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18308107%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Treatment of superficial bladder tumors: achievements and needs. The EORTC Genitourinary Group

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.09.050

7 January 2021

Long-term effect of intravesical bacillus Calmette-Guerin on flat carcinoma in situ of the bladder

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.09.050

7 January 2021

Intravesical bacillus Calmette-Guerin immunoprophylaxis of superficial bladder cancer: results of a controlled prospective trial with modified treatment schedule

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.09.050

7 January 2021

Bacillus calmette-guerin versus chemotherapy for the intravesical treatment of patients with carcinoma in situ of the bladder: a meta-analysis of the published results of randomized clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.09.050

7 January 2021

Maintenance Bacillus Calmette-Guerin for Ta T1 Bladder Tumors Is Not Associated with Increased Toxicity: Results from a European Organisation for Research and Treatment of Cancer Genito-Urinary Group Phase III Trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.09.050

7 January 2021

Urinary Interleukin-8 and 18 predict the response of superficial bladder cancer to intravesical therapy with bacillus Calmette-Guerin

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.09.050

7 January 2021

Urinary interleukin-2 may predict clinical outcome of intravesical bacillus Calmette-Gu�rin immunotherapy for carcinoma in situ of the bladder

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.09.050

7 January 2021

Urinary IL‐2 assay for monitoring intravesical bacillus Calmette‐Guérin response of superficial bladder cancer during induction course and maintenance therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.09.050

7 January 2021

Elevated urinary fibronectin levels after transurethral resection of bladder tumour: a possible role in patients failing therapy with bacillus Calmette-Guérin

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.09.050

7 January 2021

HSP90 expression: a new predictive factor for BCG response in stage Ta-T1 grade 3 bladder tumours

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.09.050

7 January 2021

Treatment options for BCG failures.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.09.050

7 January 2021

Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.09.050

7 January 2021

Bacille Calmette-Guérin in superficial transitional cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.09.050

7 January 2021

Bacillus Calmete-Guérin plus interferon-alpha2B intravesical therapy maintains an extended treatment plan for superficial bladder cancer with minimal toxicity

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.09.050

7 January 2021

Final results from a national multicenter phase II trial of combination bacillus Calmette-Guérin plus interferon alpha-2B for reducing recurrence of superficial bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.09.050

7 January 2021

Defining bacillus Calmette-Guerin refractory superficial bladder tumors

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.09.050

7 January 2021

Additional bacillus Calmette-Guérin therapy for recurrent transitional cell carcinoma after an initial complete response

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.09.050

7 January 2021

The impact of age on the response of patients with superficial bladder cancer to intravesical immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.09.050

7 January 2021

The response of patients with superficial bladder cancer to a second course of intravesical bacillus Calmette-Guerin

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.09.050

7 January 2021

Beware the BCG failures: a review of one institution's results

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.09.050

7 January 2021

Has a 3-fold decreased dose of bacillus Calmette-Guerin the same efficacy against recurrences and progression of T1G3 and Tis bladder tumors than the standard dose? Results of a prospective randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.09.050

7 January 2021

Identifiers

10.1016/J.UROLOGY.2007.09.050

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18308107%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18308107%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q80792631&oldid=1758826015"